NY Boston Fan

With earth-shattering results for a lung cancer drug released last night, Pfizer stopping a trial of Celebrex because of increased cardiovascular events, and Eyetech and Pfizer (potentially) announcing the approval of a key eye drug any minute now, I haven't had time to post.

And I won't have a computer all weekend.

So if you're visiting, check this out, and think twice before you yell at the ref next time.